June 1, 2020

BioLineRx Announces $4.39 Million Registered Direct Offering

May 27, 2020

BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine

May 26, 2020

BioLineRx Announces $9.0 Million Registered Direct Offering